Hydromer Reports 11% Revenue Growth and Return to Profitability in Q3 2025

Hydromer, Inc. (OTC: HYDI) announced certain preliminary, unaudited financial results for the quarter ended September 30, 2025. For the quarter ended September 30, 2025, Hydromer generated revenue of $0.91 million, an 11% increase compared to $0.81 million in the third quarter of 2024. The Company reported a net income of $53,000 in the third quarter. These results are based on the most current information available to management, are unaudited, and are subject to the completion of the Company's 2025 year-end financial reporting processes, reviews, audit, and potential adjustments, each of which could result in changes to the numbers reported.

Michael Torti, CEO of Hydromer, stated that the company is pleased to report continued top line growth and return to a profit-making quarter. Hydromer maintains a high level of customer loyalty and begins to see growth from new customers entering its production coating line-up. The company continues to invest in certain infrastructure and equipment needs while focusing heavily on new product development. Torti also noted the artificially low valuation of HYDI and associated difficulties in trading the stock and will be taking steps to return HYDI to the OTCID Basic Market.

Hydromer remains committed to building a scalable, innovation-driven platform and will continue to prioritize operational efficiency, customer partnerships, and next-generation technology development. The Company is a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 44 years. Additional information about the company can be found by viewing the original release on www.newmediawire.com.